Dublin, Ohio-based Cardinal Health, Inc. (CAH) manufactures and distributes pharmaceuticals, medical & laboratory products, ...

The website you are visiting is protected and accelerated by Incapsula. Your computer may have been infected by malware and ...

Wells Fargo analyst Stephen Baxter maintained Cardinal Health with an Equal-Weight and raised the price target from $135 to ...

Cardinal Health CEO Jason Hollar recounted the ... Another in-progress acquisition expands its profitable business delivering medical supplies for at-home care. Altogether the four acquisitions ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Cardinal Health (CAH – Research Report) and Apyx ...

Jefferies has upgraded Cardinal Health (CAH) to buy from hold, citing management's emerging EPS track record. Read more here.

Cardinal Health Inc. closed 4.35% short of its 52-week high of $132.84, which the company achieved on January 30th.

Second quarter revenue for Cardinal Health's global medical products and distribution segment increased 1% to $3.2 billion, driven by volume growth from existing customers. The company’s global ...

Bank of America Securities analyst Allen Lutz maintained a Buy rating on Cardinal Health (CAH – Research Report) today. The company’s shares ...